Produktname:4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline
IUPAC Name:3-methyl-4-{[1,2,4]triazolo[1,5-a]pyridin-7-yloxy}aniline
- CAS:937263-71-3
- Molekulare Formel:C13H12N4O
- Reinheit:95%+
- Katalognummer:CM322205
- Molekulargewicht:240.27
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:937263-71-3
- Molekulare Formel:C13H12N4O
- Schmelzpunkt:-
- SMILES-Code:NC1=CC=C(OC2=CC3=NC=NN3C=C2)C(C)=C1
- Dichte:
- Katalognummer:CM322205
- Molekulargewicht:240.27
- Siedepunkt:
- Mdl-Nr.:MFCD28977540
- Lagerung:Keep in a tight container and store at ambient temperature
Column Infos
- Tucatinib
- In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.